B
TENX icon

Braidwell’s Tenax Therapeutics TENX Stock Holding History

Braidwell’s Portfolio TENX Stock Details TENX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.5M Buy
+584,412
New +$7.47M 0.31% 76

Other funds holding TENX

VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Braidwell's TENX Position: Q2 2026 in Review

Braidwell opened a new position in Tenax Therapeutics (TENX) in Q2 2026: 584,412 shares worth $8.5M. The stake represents 0.31% of the portfolio and ranks #76 among its holdings.

99 funds tracked by Wall St. Rank hold TENX as of Q2 2026.

  • Braidwell held 584,412 shares of Tenax Therapeutics worth $8.5M as of Q2 2026.
  • Tenax Therapeutics was a new Braidwell position in Q2 2026.
  • Tenax Therapeutics made up 0.31% of Braidwell's portfolio in Q2 2026, its #76 holding.
  • 99 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q2 2026.

Based on Braidwell's 13F filing for Q2 2026, filed 14 Aug 2026.